文献速递新生儿儿童消化与营养

唐氏综合征新生儿早期高胆红素血症风险显著增加

Early Hyperbilirubinemia in Neonates with Down Syndrome.
PubMed 文献 · J Pediatr · 2020-01-31

研究提示对唐氏综合征新生儿应早期评估总胆红素。

要点

  • 唐氏综合征新生儿初始TSB超对照95百分位的风险为4.7倍(23.5% vs 5.0%)。
  • 唐氏综合征新生儿光疗使用率为62.2%,显著高于对照的7.0%。
  • 因黄疸再入院率为17.4 vs 4.8每1000活产,风险为3.6倍。

核心结论

  • 唐氏综合征新生儿发生早期高胆红素血症的风险显著高于对照人群。
  • 建议对唐氏综合征新生儿除早期全血细胞计数筛查外,也应评估总胆红素。

研究设计与样本

  • 回顾性队列研究,使用15年多医院数据,比较唐氏综合征新生儿与对照的胆红素水平、光疗使用及再入院率。

主要发现

  • 唐氏综合征组初始TSB超过对照95百分位的比例为23.5%,对照组为5.0%,风险为4.7倍(95% CI, 3.9-5.7; P < .0001)。
  • 唐氏综合征组光疗使用率为62.2%,对照组为7.0%,风险为8.9倍(95% CI, 8.1-9.8; P < .0001)。
  • 唐氏综合征组因黄疸再入院率为17.4每1000活产,对照组为4.8每1000活产,风险为3.6倍(95% CI, 1.6-8.2; P = .0075)。

关键数值与推荐

  • 初始TSB超过对照95百分位的风险比为4.7(95% CI, 3.9-5.7)。
  • 光疗使用风险比为8.9(95% CI, 8.1-9.8)。
  • 因黄疸再入院风险比为3.6(95% CI, 1.6-8.2)。

临床怎么用

  • 对唐氏综合征新生儿应早期监测总胆红素,而不仅依赖全血细胞计数筛查。
  • 临床可参考对照参考区间识别高风险患儿,及时干预光疗。

局限性

  • 回顾性队列设计可能存在残余混杂。
  • 数据来自多医院15年记录,未报告具体光疗指征和再入院标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare total serum bilirubin (TSB) levels, phototherapy usage, and hospital readmission for jaundice among neonates with Down syndrome vs controls. STUDY DESIGN: A retrospective cohort study using 15 years of multihospital data. We created control reference intervals (5th, median, and 95th percentiles) for initial TSB values hourly during the first days after birth, and determined the proportion of neonates with Down syndrome whose TSB exceeded the 95th percentile control interval. We determined the proportion with an initial TSB exceeding the upper control reference interval, the highest TSB recorded, the percentage of neonates receiving phototherapy, and the rate of hospital readmission for jaundice treatment. RESULTS: We compared 357 neonates with Down syndrome with 377 368 controls. Compared with controls, those with Down syndrome had 4.7 times the risk (95% CI, 3.9-5.7; P < .0001) of an initial TSB exceeding the 95th percentile control interval (23.5% vs 5.0%), 8.9 times (95% CI, 8.1-9.8; P < .0001) the phototherapy usage (62.2% vs 7.0%), and 3.6 times (95% CI, 1.6-8.2; P = .0075) the readmission rate for jaundice (17.4 vs 4.8 per 1000 live births). CONCLUSIONS: Neonates with Down syndrome have a substantial risk of early hyperbilirubinemia. The American Academy of Pediatrics currently advises obtaining an early screening complete blood count from neonates with Down syndrome. We submit that assessing their TSB is also advisable.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Bahr TM, Henry E, Hulse W, et al. Early Hyperbilirubinemia in Neonates with Down Syndrome. J Pediatr. 2020. PMID: 32014279. doi:10.1016/j.jpeds.2019.12.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。